Revenue | $10 - $100 million See Exact Annual Revenue |
---|---|
Employees | 10 - 100Exact Company Size |
Primary Industry | 4242 Drugs & Druggists' Sundries Merchant Wholesalers |
Additional NAICS Codes | 325412 Pharmaceutical Preparation Manufacturing |
Address | 2117 Sw Highway 484 Ocala, FL 32801 |
AIM ImmunoTech | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | $10 - $100 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
AIM ImmunoTech P&L | $ Millions |
---|---|
Revenue (Sales) | ![]() |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
AIM Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant | 02/07/2020 |
AMPLIFIED IMMUNO MODULATION INC. Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant | 08/22/2019 |
HEMISPHERX Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS | 06/07/2019 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
AMERISOURCEBERGEN | Conshohocken, PA | 100 |
MCKESSON | Irving, TX | 58 |
CARDINAL HEALTH 119 | Dublin, OH | 42 |
TAKEDA PHARMACEUTICALS AMERICA | Lexington, MA | 31 |
CATALENT PHARMA SOLUTIONS | Somerset, NJ | 13 |
OWENS & MINOR DISTRIBUTION | Mechanicsville, VA | 11 |
J M SMITH | Spartanburg, SC | 3 |
DAIICHI SANKYO | Basking Ridge, NJ | 3 |
HIKMA PHARMACEUTICALS USA | Berkeley Heights, NJ | 2 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
XEC | Orlando, FL | 100 |
JUBILANT DRAXIMAGE RADIOPHARMACIES | Orlando, FL | 22 |
AIM IMMUNOTECH | Ocala, FL | 6 |
PRO SKIN SOLUTIONS | Orlando, FL | 2 |
STAR-LIGHT CREATIONS | Orlando, FL | 1 |
Company | Revenue ($ MM) |
---|---|
![]() |